PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Joshi Clinic and Lilavati Hospital and Research Center, Mumbai, India.\', \'Lilavati Hospital and Research Center, Mumbai, India.\', \'Critical Care Services, Nanavati Super Specialty Hospital, Mumbai, India.\', \'Vora Clinic, Mumbai, India.\', \'Metro Respiratory Centre, Noida, India.\', \'Shilpa Medical Research Centre, Mumbai, India.\', \'Global Medical Affairs, India Formulations, Glenmark Pharmaceuticals Ltd., Mumbai, India. Electronic address: saiprasad.patil@glenmarkpharma.com.\', \'Global Medical Affairs, India Formulations and Middle East Africa, Glenmark Pharmaceuticals Ltd., Mumbai, India.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S1201-9712(20)32273-610.1016/j.ijid.2020.10.069
?:hasPublicationType
?:journal
  • International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
is ?:pmid of
?:pmid
?:pmid
  • 33130203
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
?:title
  • Role of favipiravir in the treatment of COVID-19.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all